Drugs / Arotinib
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05380271 | Jul → Dec 2022 | non-small cell lung carcinoma | Gang Wu | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Arotinib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05380271 ↗ |
| Route | Oral | “Arotinib, 8-12mg, oral (stop oral for 1W every 3W).” NCT05380271 ↗ |